Funding opportunities and RFIs to support research relating to COVID-19 from various agencies/organizations are listed below; please note that this list is not exhaustive. The list will be updated Mondays, Wednesdays, and Fridays by 5 pm. Please contact [email protected] to add a funding opportunity or with any questions.
Proposals for critical continuing laboratory research at Brown that could impact the diagnosis or treatment of COVID-19 in the current crisis should be sent to [email protected] for review and approval.
Research on the potential impact of primary instruction settings disruptions (e.g., pre-school, elementary school) on the mental health, cognitive, social, and emotional development of children. Empirical data would aid in balancing health risks for various public health mitigation strategies affecting children in the current pandemic as well as inform how to both be prepared and respond to future public health emergencies, including pandemics and disaster scenarios. Apply via PA-20-185.
Funding to explore and address the urgent and unique needs to build capacity for stakeholder engagement in PCOR/CER specifically related to long-term effects of post-acute COVID-19; impact of COVID-19 on disproportionately affected populations; impact of COVID-19 on social isolation and loneliness (mental health and well-being); and engaging, educating, and promoting informed decision making around COVID-19 vaccines.
Funding for supplements to human subjects awards administered by the NINDS to conduct research on the effects of COVID-19 on the development of, or disease progression in, Alzheimer's Disease-Related Dementias (ADRDs). Topics include: the effect of symptomatic or asymptomatic COVID-19 infection on progression to cognitive impairment or dementia in (1) populations at risk for ADRDs, (2) patients with existing ADRDs; evidence of new or worsening ADRD-related neurophysiology that occur after COVID-19 infection. Apply via PA-20-272.
The EPA is working to improve the environment and public health conditions of low-income communities and communities of color through the advancement of racial equity and environmental justice. This announcement places emphasis on projects focusing on COVID-19 impacts, as well as climate and disaster resiliency.
Provides support to relevant active NIH-supported grants to address the following scientific priorities: Understand the effects of SARS-CoV-2 infection and the COVID-19 pandemic on maternal mental health, well-being, functioning and quality of life; Identify psychosocial and behavioral health risk factors related to the COVID-19 pandemic that affect maternal mental health and functioning outcomes; Address the impact of structural racism and discrimination (SRD) on maternal health outcomes in the context of COVID-19.
Biomedical, Clinical Research, Technology development
Research Area 001: Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases; Research Area 002: Development of Therapeutic Products for Biodefense, AntiMicrobial Resistant (AMR) Infections and Emerging Infectious Diseases; Research Area 003: Advanced Development of Sequencing Based Diagnostics for Biothreats and Emerging Infectious Diseases
Supports research to rapidly expand the knowledge base on acute and long-term neurological and neurocognitive sequelae of COVID-19. New and resubmission applications to address significant questions about the neurological and neurocognitive impacts of COVID-19 infection in aging and the interaction in older adults of COVID-19 with comorbid conditions, including Alzheimer’s disease (AD) and AD-related dementias (ADRD).
NIGMS will accept the submission of applications for Competitive Revisions to all active NIGMS grants to address only the following research area: Incorporation of data related to SARS-CoV-2 into ongoing research efforts to develop predictive computational models for the spread of SARS-CoV-2 and other related infectious agents.
up to $250,000 direct costs per year over up to 3 years
Public Health, Social Sciences
Supports research grants to address urgent, time-sensitive research questions on the relationships between alcohol consumption and COVID-19 related outcomes and consequences. The principal area of focus is research that can improve public health in the near term by informing responses to the current COVID-19 pandemic, in view of 1) the impact of alcohol misuse on incidence and severity of COVID-19 disease or 2) the effect of the COVID-19 disease and pandemic-induced restrictions on alcohol use and alcohol use disorder (AUD). Also offered as a R03 and R21.
Supports projects that will rapidly improve our understanding of the behavioral, social, and economic effects of the pandemic and to enhance our ability to control its spread, particularly as relates to NIH-designated health disparity populations, and other COVID-19 vulnerable groups including older adults. Apply via one of 12 FOAs mentioned in the NOSI.
Solicits community-engaged research to: 1) evaluate intervention strategies (e.g., expand reach, access) to facilitate vaccination (including for COVID-19) uptake in clinical and community contexts; and 2) address the barriers to increasing reach, access, and uptake of vaccinations among health disparity populations at high risk and likely to experience vaccine hesitancy. Apply via PA-20-183 or PA-20-185.
Biomedical, Clinical Research, Technology Development
Seeks highly collaborative, multi-disciplinary Program Projects that incorporate understanding of CoV virology and immunology, immunogen design, and innovative vaccine and adjuvant platforms and technologies to discover, design, and develop pan-coronavirus (pan-CoV) vaccine candidates that provide broad protective immunity to multiple CoV strains. Apply via PAR-20-072.
Encourages applications in three areas related to the intersection of COVID-19, the associated mitigation actions, and rehabilitation: research to address the rehabilitation needs of survivors of COVID-19; understand the impact of disruptions to rehabilitation services caused by the COVID-19 pandemic and associated mitigation actions; understand the social, behavioral, economic, and health impact of the COVID-19 pandemic and the associated mitigation actions on people with physical disabilities. Apply via PA-20-185 (R01), PA-18-480 (R01), PA-20-200 (R03), or PA-20-194 (R21).
Invites applications proposing cutting-edge research on emerging viral infections that are thought to primarily impact non-reproductive sites, at least at initial presentation, but may also affect the male and/or female reproductive tract. Investigate possible effects of emerging viruses on reproductive tissues and cells to better understand potential impacts on fertility that may be sex specific. Apply via PA-20-185 or PA-18-482.
Encourages cooperative agreement applications for implementation of investigator-initiated high-risk clinical trials that will augment ongoing and planned clinical trials of therapeutic and vaccine candidates directed against SARS-CoV-2 to evaluate: SARS-CoV-2 candidate vaccines; non-vaccine biomedical prevention of SARS-CoV-2 infection and/or COVID-19; therapeutic approaches to treat COVID-19. Apply via PAR-18-633.
NIAID is allowing the submission of applications for Competitive Revisions to active grants to increase and enhance select research efforts to facilitate the Federal SARS-CoV-2/COVID-19 research response. Areas of interest are limited to: Support to BSL3 facilities actively engaged in the SARS-CoV-2/COVID-19 research response; Generation of critical reagents to support the SARS-CoV-2/COVID-19 research response; Expansion of relevant data systems to expeditiously share SARS-CoV-2/COVID-19 research resources with the broad research community; Expansion of clinical trial infrastructure, or site preparation, for urgent SARS-CoV-2/COVID-19 clinical trial activities. See the NOSI for details; apply via PA-20-135
NCI anticipates that in infrequent cases, NCI-funded investigators will have novel insights and research proposals of immediate relevance to SARS-CoV-2 and COVID-19. In those cases, but only for the duration of the present crisis, NCI would consider requests from its funded grantees and cooperative agreement awardees to engage in limited COVID-19 related research using part of their existing NCI-funded resources.
Remote Access, in-kind Lab labor; not a monetary grant
Biomedical, Clinical Research
Oak Ridge National Laboratory (ORNL) is currently restricting site access. Rapid Access proposals will be performed as remote access experiments with limited internal staff. The Department of Energy Basic Energy Sciences advanced neutron sources will provide remote rapid access to advanced user facilities to support research into the COVID-19 virus and the search for effective diagnostics and therapies. Facilities that will be made available at the Spallation Neutron Source (SNS) and High Flux Isotope Reactor (HFIR) at ORNL , include neutron macromolecular crystallography, small-angle scattering, reflectometry, spectroscopy and imaging beamlines.
Urgent competitive revisions and administrative supplements to existing grants to assess the impact of alcohol as a biological contributor to COVID-19 outcomes, to assess behavioral, social, and economic consequences of the pandemic and to assess the responses that the pandemic has provoked as they relate to alcohol consumption and related outcomes. Apply via PA-18-935 or PA-18-591.
Impact of environmental exposures on COVID-19; the role of environmental exposures in pathogenicity, transmission, individual susceptibility, or prevention and intervention strategies. Apply via PA-20-135.
Strengthen the mental health response to COVID-19 and to future public health emergencies; research addressing the intersection of COVID-19, mental health, and HIV treatment and prevention. Apply via PA-18-935 or PA-18-591.
Impact of the novel Coronavirus pandemic causing COVID-19 disease outbreaks and the resulting disruptions on individual and social wellbeing, health services use, and health outcomes for NIH-designated health disparity populations. Apply via PA-18-935 or PA-18-591.
NIA & NIMH are offering Supplements & Revisions to certain active grants. NIA: improve prevention of disease transmission among older adults and mitigation of disease severity and mortality in older adults with COVID-19. NIMH: examine how a disrupted workforce may adequately respond/adapt to and maintain services or provide additional care for new or worsening mental health needs and/or suicide risk in midlife and older age adults. Apply via PA-18-935 or PA-18-591.
Google is offering Google Cloud credits for researchers to leverage their computing capabilities and infrastructure as they study potential therapies and vaccines, track critical data, and identify new ways to combat COVID-19
Biomedical, Clinical Research, Technology development
The U.S. government is providing a portal for the 2019 novel coronavirus (COVID-19) medical countermeasures task force as a single point of entry for the submission of ideas and information regarding diagnostics, therapeutics, vaccines, and other products or technologies relevant to addressing this outbreak.
The DARPA technical offices that are focused on COVID-19 efforts are the Defense Sciences Office (DSO) and the Biological Technology Office (BTO), both of which have Office-Wide Broad Agency Announcements (BAA) that are open for the submission of new ideas at any time.